PRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. While the chart setup is mildly bullish (stacked moving averages and improving MACD), the stock is pressing near resistance with RSI near overbought, options positioning is heavily put-skewed (bearish/defensive), and the latest quarter showed a steep profitability collapse. For an impatient buyer who wants to act immediately, the risk/reward is not attractive at ~$24.23 without a clearer catalyst or pullback.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests an established uptrend. Momentum: MACD histogram is above zero and expanding (0.00506), supporting ongoing upside momentum. RSI(6)=69.33 is near overbought, implying upside may be limited near-term and a pause/pullback risk is rising. Levels: Pivot 24.186. Immediate resistance is tight overhead (R1 24.262, R2 24.309), meaning price is close to a supply zone; supports sit at S1 24.109 and S2 24.062. Quant pattern read: Similar-pattern projection implies modest upside next day/week (+0.57% / +1.26%) but slight weakness over a month (-0.95%), aligning with a near-term grind higher but limited follow-through.
Intellectia Proprietary Trading Signals
Technical uptrend remains intact (bullish MA alignment + improving MACD).
No negative news flow in the last week.
Upcoming earnings (2026-02-23 after hours) could reset expectations if profitability rebounds (consensus EPS est. ~0.22 provided in calendar).
with RSI near overbought, increasing the odds of a stall or pullback rather than an immediate clean breakout.
Latest quarter: 2025/Q3. Revenue: $275.28M, down 1.12% YoY (slight contraction). Net income: $1.45M, down 91.20% YoY (sharp decline). EPS: $0.03, down 90.62% YoY (major earnings compression). Overall: The core concern is not revenue but the collapse in profitability, which undermines confidence in buying aggressively at current levels without evidence of margin/earnings recovery.
No analyst rating/price-target change data was provided, so a recent Wall Street upgrade/downgrade trend cannot be confirmed from the dataset. Pros (typical bull case given available data): improving technical trend; potential earnings rebound into the next report. Cons (bear case supported by data): severe YoY earnings drop; defensive options positioning; lack of visible near-term catalysts/news.
